Urch PublishingUrch Publishing is a UK-based business information provider dedicated to providing pharmaceutical industry executives the information they need in their jobs. All publications and information products are carefully researched by experts and written in a clear and succinct style.Busy executives can rely on Urch Publishing to make their life easier as Urch has committed itself to 3 simple principles. 1. Quality Urch prides itself on always offering quality products, directly relevant to your business. All publications are based on expert analysis, informed opinion and both primary and secondary research. 2. Understanding Urch realizes that all executives are time-poor and under considerable pressure. All publications are all designed to save time by identifying the information you need in your job. 3. Customer Service Although most Urch customers are from large organizations, we realize that it is individuals who make up these companies and chose to buy our products. We strive to offer our customers the best possible service by ensuring our customer service staff fulfill your order as quickly as possible and can answer any question you may have. |
List of reports from Urch Publishing
|
2007 Pharmaceutical Product Approval Trends: Key Market Benchmarks and Strategic Insights
12/1/2007 | published by: Urch Publishing
... approved, assesses major companies and identifies key trends and opportunities in order to help inform pharmaceutical decision-making, particularly in the areas of corporate planning, portfolio management and market forecasting. Selected Headline Findings The US and ...
|
more...
|
$2,699.00
|
|
The Billion Dollar Pharmaceutical Club: Profiles of the Leading European Players
9/1/2000 | published by: Urch Publishing
... reviewing financial and market share data. The profiles provide analyses of corporate structure and development; geographic organisation; pharmaceutical portfolio by therapy area, highlighting leading products sales and trends; major commercial collaborations; R&D alliances, strategies and ...
|
more...
|
$178.20
|
|
The Billion Dollar Pharmaceutical Club: Profiles of the Leading Japanese Players
8/1/2000 | published by: Urch Publishing
... reviewing financial and market share data. The profiles provide analyses of corporate structure and development; geographic organisation; pharmaceutical portfolio by therapy area, highlighting leading products sales and trends; major commercial collaborations; R&D alliances, strategies and ...
|
more...
|
$178.20
|
|
The Billion Dollar Pharmaceutical Club: Profiles of the Leading US Players
8/1/2000 | published by: Urch Publishing
... reviewing financial and market share data. The profiles provide analyses of corporate structure and development; geographic organisation; pharmaceutical portfolio by therapy area, highlighting leading products sales and trends; major commercial collaborations; R&D alliances, strategies and ...
|
more...
|
$178.20
|
|
Biosimilars: A Growing Market
3/1/2010 | published by: Urch Publishing
... there has been a steady breakdown of regulatory resistance. However, there are considerable entry barriers hindering companies that wish to enter this field of therapeutics. Biosimilars - A Growing Market is a unique report from ...
|
more...
|
$2,345.00
|
|
Cancer Market Trends 2006 - 2010
12/1/2006 | published by: Urch Publishing
... global pharmaceutical sales. Although growth rates for this market will slow due to generic competition the market is predicted to expand to $85.3 billion by 2010 equivalent to CAGR of 11.1% Cancer Market Trends, 2006-2010 ...
|
more...
|
$2,071.00
|
|
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 - Key Market Forecasts and Growth Opportunities
8/1/2007 | published by: Urch Publishing
... the next five years. The slow-down in cardiovascular market growth between 2003 and 2005 is forecast to continue through to 2010. While continued changes in demographics and lifestyle will continue to drive cardiovascular sales forward, ...
|
more...
|
$1,811.23
|
|
China Pharmaceuticals Guide: New Policy and Regulation
6/1/2000 | published by: Urch Publishing
... Concept Consulting, the Chinese Information Centre of The State Drug Administration (SDA) and Informa Pharmaceuticals have prepared the China Pharmaceuticals Guide - a definitive reference manual to the regulation of pharmaceuticals in this exciting market.
|
more...
|
$360.00
|
|
CNS Market Trends, 2007 to 2010
6/1/2007 | published by: Urch Publishing
... increased by 19% and accounted for 9.2% of total global pharmaceutical sales in 2005. Annual global CNS sales growth slowed from 11.5% in 2004 to 6.6% in 2005 as a result of generic competition for ...
|
more...
|
$2,110.00
|
|
Cost Containment in Healthcare: Putting the Pharmaceutical Industry in Perspective
8/1/2000 | published by: Urch Publishing
... actions policy-makers, providers and payers have taken to tackle the healthcare problems associtated with an ageing population, rising patient expectations, system inefficiencies, high costs of new drugs and treatments and keeping up with technology developments.
|
more...
|
$178.20
|
|
Customer-Driven Pharmaceutical Marketing: developing and exploiting profitable relationships
3/30/2001 | published by: Urch Publishing
... by pharmaceutical management with decreasingly satisfying results. Mergers and acquisitions are being consummated with only short-term, ad hoc, quick fix results. Traditional schools of strategic thinking offer a number of perspectives on how to compete.
|
more...
|
$225.00
|
|
Drug Discovery: Current Trends and Future Prospects
2/1/2001 | published by: Urch Publishing
... numbers of compounds used in screening against biological targets, and technologies for target validation (antisense, gene knockout, functional genetic screens, gene expression arrays and proteomic approaches). Learn how new drug targets are identified, and the ...
|
more...
|
$560.00
|
|
Emerging Pharmaceutical Markets - Potential & Problems
10/26/2001 | published by: Urch Publishing
... drug development and approval in the three regions, thus providing patients with more timely access to new medicines. The current major focus of ICH is development of a Common Technical Document that would form the ...
|
more...
|
$351.00
|
|
EU Accession by Central and Eastern European Countries: Issues for Researched-Based Pharmaceutical Companies
10/1/2000 | published by: Urch Publishing
European Union enlargement to the east brings both threats and opportunities to multinational pharmaceutical companies. This report documents the changes in this sector that will affect all companies.
|
more...
|
$306.00
|
|
European Generic Drug Markets - Growth to 2007
11/1/2002 | published by: Urch Publishing
... pressures on healthcare services and organisations will lead to increased adoption of generic substitution and prescribing practices in many EU Member States boosting volume and value for the industry. Other factors such as patent expiry ...
|
more...
|
$891.00
|
|
The Future of European Pharmaceutical Distribution
7/1/2010 | published by: Urch Publishing
... dramatically over the next few years. The adoption of direct-to-pharmacy (DTP) in the UK and its emergence in Poland sets a potential precedent for other European markets. To date, pharmaceutical manufacturers have managed to drive ...
|
more...
|
$2,975.00
|
|
Generic Competition 2009 to 2013
4/1/2009 | published by: Urch Publishing
... Lipitor and Plavix are now expected toface generic competition. The period 2009-13 will see major companies facing very different degrees of exposure to the potential loss of revenue to generics. Eli Lilly, Pfizer, Bristol-Myers Squibb, ...
|
more...
|
$1,650.00
|
|
Global Pharmaceutical Fine Chemicals
7/1/2004 | published by: Urch Publishing
... serve the various sub-sectors of the pharmaceutical industry and what factors will affect the industry. This unique document will give you and your organisation the knowledge of how pharmaceutical fine chemicals are manufactured and sold, ...
|
more...
|
$1,665.00
|
|
Good Laboratory And Good Clinical Practice: Requirements For Compliance - Management Involvement And Cost Implications
3/1/2001 | published by: Urch Publishing
... even more important to ensure that studies are correctly carried out and in compliance with the regulations. This definitive new guide sets out to review the Good Laboratory and Good Clinical Practice compliance guidelines and ...
|
more...
|
$72.00
|
|
The Guide to Pharmaceutical Pricing & Reimbursement Systems: Western Europe
11/1/2005 | published by: Urch Publishing
... operates and sells its products. The Guide to Pharmaceutical Pricing and Reimbursement Systems: Western Europe is a straightforward guide to the pricing and reimbursement mechanisms in the major European markets. The Guide will: save you ...
|
more...
|
$1,746.00
|
|
Health Economics in the Drug Life Cycle: Achieving success in drug discovery, development, reimbursement and marketing
1/1/2003 | published by: Urch Publishing
... early stage in the drug development process. If correctly applied, health economics techniques will deliver a product unit price which creates a win-win situation between the manufacturer and the purchaser or prescriber of the drug, ...
|
more...
|
$1,251.00
|
|
Healthcare & Pharmaceuticals in Latin America - A guide to the markets and regulations
9/1/2011 | published by: Urch Publishing
... past economic crises and their causes before becoming involved. Latin America continues to be a region of promising opportunities for commercial pharmaceutical organisations. The region represents a growing consumer base for the drug industry as ...
|
more...
|
$2,345.00
|
|
A Healthy Business Guide to the Pharmaceutical Industry
1/1/2001 | published by: Urch Publishing
... R&D stages through to clinical trials, launch, post marketing and product life-cycle. The author examines how companies are built, what has been successful, future growth area and where the industry is headed as a whole.
|
more...
|
$81.00
|
|
Major Pharmaceutical Markets of the Middle East
2/14/2009 | published by: Urch Publishing
... to become self-sufficient in pharmaceuticals production.” Major Pharmaceutical Markets of the Middle East (2nd Edition) is a comprehensive report providing extensive coverage of one of the strongest emerging markets. Through quality analysis and forecasts, this ...
|
more...
|
$2,030.00
|
|
Manufacturing in the Global Pharmaceuticals Industry
9/1/2008 | published by: Urch Publishing
... ed) is the only report available that covers this crucial area of the pharmaceutical industry in such depth. The concentration in recent years on creating organisations that are market or customer-led, or research-driven has taken ...
|
more...
|
$1,465.00
|

